TSPAN15 interacts with BTRC to promote oesophageal squamous cell carcinoma metastasis via activating NF-κB signaling.
Baozhu ZhangZhao ZhangLei LiYan-Ru QinHaibo LiuChen JiangTing-Ting ZengMeng-Qing LiDan XieYan LiXin-Yuan GuanYing-Hui ZhuPublished in: Nature communications (2018)
Beta-transducin repeat containing E3 ubiquitin protein ligase (BTRC) is crucial for the degradation of IκBα. Our previous transcriptome sequencing analysis revealed that tetraspanin 15 (TSPAN15) was significantly upregulated in clinical oesophageal squamous cell carcinoma (OSCC) tissues. Here, we show that high TSPAN15 expression in OSCC tissues is significantly associated with lymph node and distant metastasis, advanced clinical stage, and poor prognosis. Elevated TSPAN15 expression is, in part, caused by the reduction of miR-339-5p. Functional studies demonstrate that TSPAN15 promotes metastatic capabilities of OSCC cells. We further show that TSPAN15 specifically interacts with BTRC to promote the ubiquitination and proteasomal degradation of p-IκBα, and thereby triggers NF-κB nuclear translocation and subsequent activation of transcription of several metastasis-related genes, including ICAM1, VCAM1, uPA, MMP9, TNFα, and CCL2. Collectively, our findings indicate that TSPAN15 may serve as a new biomarker and/or provide a novel therapeutic target to OSCC patients.
Keyphrases
- poor prognosis
- squamous cell carcinoma
- lymph node
- long non coding rna
- signaling pathway
- binding protein
- gene expression
- single cell
- end stage renal disease
- ejection fraction
- induced apoptosis
- oxidative stress
- rheumatoid arthritis
- newly diagnosed
- chronic kidney disease
- lps induced
- lymph node metastasis
- early stage
- rna seq
- transcription factor
- prognostic factors
- locally advanced
- inflammatory response
- endoplasmic reticulum stress
- toll like receptor
- protein protein